UPMC Hillman Cancer Center Research Program Leaders

More than 300 members, representing 42 University departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer prevention, epidemiology, and biobehavioral factors in cancer.

Robert L. Ferris, MD, PhD Director, UPMC Hillman Cancer Center
Catherine Bender, PhD Co-Leader, Biobehavioral Oncology Program
Dana Bovbjerg, PhD Co-Leader, Biobehavioral Oncology Program
Adam Brufsky, MD, PhD Associate Director, Translational Research
Co-Leader, Cancer Therapeutics Program
Ronald Buckanovich, MD, PhD Co-Leader, Cancer Biology Program
Edward Chu, MD Deputy Director, UPMC Hillman Cancer Center
Co-Leader, Cancer Therapeutics Program
Leisha Emens, MD, PhD Co-Leader, Cancer Immunology and Immunotherapy Program
Shou-Jiang (SJ) Gao, PhD Leader, Cancer Virology Program
James Herman, MD Co-Leader, Cancer Epidemiology and Prevention Program
Bennett Van Houten, PhD Co-Leader, Genome Stability Program
Steffi Oesterreich, PhD Co-Leader, Cancer Biology Program
Patricia Opresko, PhD Co-Leader, Genome Stability Program
Dario Vignali, PhD Co-Leader, Cancer Immunology and Immunotherapy Program
Peter Wipf, PhD Co-Leader, Cancer Therapeutics Program
Jian-Min Yuan, MD, PhD Associate Director, Cancer Control and Population Sciences
Co-Leader, Cancer Epidemiology and Prevention Program
Hassane Zarour, MD Co-Leader, Cancer Immunology and Immunotherapy Program